Answers are grounded in this paper and cite their sources.
Objective: Posaconazole (PCZ) is an antifungal drug, which acts by inhibiting the lanosterol-14α-demethylase enzyme. It is a biopharmaceutical classification system class II drug with its bioavailability being limited by poor aqueous solubility. The aim of this study was to improve the oral bioavailability of PCZ by preparing nanocrystalline solid dispersion (NCS).
No takes yet. Share an insight, caveat, or question.
Rayapolu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: